Economic analysis of neoadjuvant chemotherapy versus primary debulking surgery for bulky advanced epithelial ovarian cancer using an aggressive surgical paradigm

. Author manuscript; available in PMC: 2019 Jul 1.

Published in final edited form as: Int J Gynecol Cancer. 2018 Jul;28(6):1077–1084. doi: 10.1097/IGC.0000000000001271

Figure 2. Incremental cost-effectiveness ratio plane showing results of probabilistic sensitivity analysis of decision tree analysis of neoadjuvant chemotherapy versus primary debulking surgery for bulky advanced epithelial ovarian cancer.